Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Kraig Biocraft Laboratories (KBLB) Equity Ratio (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Equity Ratio for 11 consecutive years, with 0.76 as the latest value for Q3 2022.

  • Quarterly Equity Ratio rose 57.15% to 0.76 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was 0.76 through Sep 2022, up 57.15% year-over-year, with the annual reading at 1.75 for FY2021, N/A changed from the prior year.
  • Equity Ratio hit 0.76 in Q3 2022 for Kraig Biocraft Laboratories, down from 0.69 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.69 in Q2 2022 to a low of 62.47 in Q4 2018.
  • Historically, Equity Ratio has averaged 10.59 across 4 years, with a median of 3.23 in 2019.
  • Biggest five-year swings in Equity Ratio: tumbled 153.25% in 2018 and later surged 85.37% in 2019.
  • Year by year, Equity Ratio stood at 62.47 in 2018, then surged by 91.8% to 5.13 in 2019, then surged by 65.81% to 1.75 in 2021, then soared by 56.71% to 0.76 in 2022.
  • Business Quant data shows Equity Ratio for KBLB at 0.76 in Q3 2022, 0.69 in Q2 2022, and 0.89 in Q1 2022.